abstract |
Methods of inhibiting LDL oxidation, atherosclerosis, advanced glycosylation end products, and superoxide anions and other reactive oxygen intermediates, comprising administering to a human or other mammal in need of treatment an effective amount of a compound having the formula (I) wherein R1 and R3 are independently hydrogen, -CH3, , or , wherein Ar is optionally substituted phenyl; R2 is , , or and pharmaceutically acceptable salts and solvates thereof. |